Literature DB >> 20488229

Gastric emptying of multi-particulate dosage forms.

J Michael Newton1.   

Abstract

The evidence in the literature for the concept that multi-particulate dosage forms below a specific size empty from the stomach as if they were liquids and hence have the potential to provide the best solution to the formulation of controlled release oral dosage forms, has been considered. There is some evidence that particles less than 1.0mm provide a more rapid response than larger size particles but there is also evidence that this is not always the case and that rapid and reproducible gastric emptying of small particles does not always occur when they are administered. There is strong evidence that food can delay the gastric emptying of multi-particulate systems. Some of the misconception for gastric emptying performance of multi-particulate system is shown to be related to the limitation of the study design and limitation of the way the data is processed. Nevertheless, there is clear evidence that multi-particulate systems can provide effective oral controlled release dosage forms. There is still some way to go with experimental techniques which would allow a definitive answer to the issue of how the variability of the gastric emptying of multi-particulate systems of less than 2.0mm arises. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20488229     DOI: 10.1016/j.ijpharm.2010.04.047

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Relationships between the properties of self-emulsifying pellets and of the emulsions used as massing liquids for their preparation.

Authors:  Ioannis Nikolakakis; Athanasia Panagopoulou; Andrea Salis; Stavros Malamataris
Journal:  AAPS PharmSciTech       Date:  2014-09-12       Impact factor: 3.246

2.  Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.

Authors:  Anh Q Vo; Xin Feng; Manjeet Pimparade; Xinyou Ye; Dong Wuk Kim; Scott T Martin; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2017-02-28       Impact factor: 4.384

Review 3.  Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.

Authors:  Timothy R Lex; Jason D Rodriguez; Lei Zhang; Wenlei Jiang; Zongming Gao
Journal:  AAPS J       Date:  2022-03-11       Impact factor: 4.009

4.  Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

5.  Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure.

Authors:  Chang-Moon Lee; Hwan-Jeong Jeong; Kuk-No Yun; Dong Wook Kim; Myung-Hee Sohn; Jong Kwon Lee; Jayoung Jeong; Seok Tae Lim
Journal:  Int J Nanomedicine       Date:  2012-06-27

6.  Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models.

Authors:  Christian Wagner; Filippos Kesisoglou; Xavier J H Pepin; Neil Parrott; Arian Emami Riedmaier
Journal:  AAPS J       Date:  2021-06-17       Impact factor: 4.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.